ModelEdge

Jounce Therapeutics Inc

Filing Type	8-K
Filing Date	2/22/2023
Updated	2/22/23, 11:11 PM

Filing

Earnings Release

Exhibits

8-KMaterial Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD

EX-99.1Material Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD

EX-99.2Material Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD

EX-99.3Material Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD

EX-99.4Material Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD

EX-99.5Material Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD

EX-99.6Material Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD

EX-99.7Material Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD

EX-99.8Material Contracts, Costs of Shutting Down or Selling Parts of the Business, Unregistered Sales of Equity Securities, Changes in Board, Management or Compensation, Reg. FD